# Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer

> **NCT04068649** · PHASE2 · RECRUITING · sponsor: **Roswell Park Cancer Institute** · enrollment: 1500 (estimated)

## Conditions studied

- Metastatic Malignant Neoplasm

## Interventions

- **RADIATION:** Palliative Radiation Therapy
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **RADIATION:** Stereotactic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT04068649
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-11-18
- **Primary completion:** 2027-11-18
- **Final completion:** 2027-11-18
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04068649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04068649, "Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04068649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*